Zobrazeno 1 - 10
of 221
pro vyhledávání: '"Carolyn J Crandall"'
Autor:
Carolyn J Crandall, Lucia Y Chen, Tyler D Rodriguez, David Elashoff, Stephanie S Faubion, Juliana M Kling, Jan Shifren, Lisa Skinner, Douglas C Bauer
Publikováno v:
JBMR Plus, Vol 5, Iss 8, Pp n/a-n/a (2021)
ABSTRACT Large‐scale studies have not addressed the knowledge level of US resident physicians regarding osteoporosis management. We gauged the knowledge level of family medicine, internal medicine, and obstetrics and gynecology resident physicians
Externí odkaz:
https://doaj.org/article/c333e70b2c5849d693c11a2a49ac4547
Autor:
Carolyn J Crandall, Joseph Larson, Jane A Cauley, John T Schousboe, Andrea Z LaCroix, John A Robbins, Nelson B Watts, Kristine E Ensrud
Publikováno v:
JBMR Plus, Vol 3, Iss 12, Pp n/a-n/a (2019)
ABSTRACT The ability of the fracture risk assessment tool (FRAX) to discriminate between women who do and do not experience major osteoporotic fractures (MOFs) is suboptimal. Adding common clinical risk factors may improve discrimination. We used dat
Externí odkaz:
https://doaj.org/article/2e285a99823f471f85ae3a834b0cffe8
Publikováno v:
JBMR Plus, Vol 3, Iss 11, Pp n/a-n/a (2019)
ABSTRACT Teriparatide, currently only available in brand form in the United States, is a costly drug approved for the treatment of postmenopausal osteoporotic women who are at high risk of fracture. Because market exclusivity for brand teriparatide e
Externí odkaz:
https://doaj.org/article/ad0a37d0937f4ef48cd8e8acd7cfda02
Autor:
Kristen M Beavers, Rebecca H Neiberg, Karen C Johnson, C Hunter Davis, Ramon Casanova, Ann V Schwartz, Carolyn J Crandall, Cora E Lewis, Xavier Pi‐Sunyer, Stephen B Kritchevsky, the Look AHEAD Research Group
Publikováno v:
JBMR Plus, Vol 3, Iss 5, Pp n/a-n/a (2019)
Abstract The purpose of this study is to explore the impact of body weight change following intentional weight loss on incident fracture and bone mineral density (BMD) in overweight and obese adults with diabetes. A total of 1885 individuals with typ
Externí odkaz:
https://doaj.org/article/cbec7b30a98b475e89cfe242a2213739
Autor:
Kristine E. Ensrud, Joseph C. Larson, Katherine A. Guthrie, Carolyn J. Crandall, Andrea Z. LaCroix, Susan D. Reed, Shalender Bhasin, Caroline M. Mitchell, Hadine Joffe
Publikováno v:
Menopause (New York, N.Y.). 29(9)
The aim of this study was to quantify changes in serum total estradiol (E2) and estrone (E1) concentrations with initiation of low-dose oral estradiol treatment and evaluate whether changes in concentrations mediate the effect of treatment in reducin
Autor:
Lindsey J. Mattick, Jennifer W. Bea, Kathy M. Hovey, Jean Wactawski-Wende, Jane A. Cauley, Carolyn J. Crandall, Lili Tian, Heather M. Ochs-Balcom
Publikováno v:
Osteoporosis International. 34:693-701
Autor:
Carolyn J. Crandall, Joseph C. Larson, Kristine E. Ensrud, Andrea Z. LaCroix, Katherine A. Guthrie, Susan D. Reed, Shalender Bhasin, Susan Diem
Publikováno v:
Maturitas. 162:23-30
To evaluate whether single measurements of serum estradiol (EWe analyzed baseline data from two clinical trials conducted in 2012-2017: MsFLASH 03 (178 peri-/post-menopausal women aged 40-62 years with bothersome vasomotor symptoms, mean age 54) and
Autor:
Carolyn J. Crandall, Joseph C. Larson, John T. Schousboe, JoAnn E. Manson, Nelson B. Watts, John A. Robbins, Peter Schnatz, Rami Nassir, Aladdin H. Shadyab, Karen C. Johnson, Jane A. Cauley, Kristine E. Ensrud
Publikováno v:
JAMA Internal Medicine.
ImportanceThe best approach to identify younger postmenopausal women for osteoporosis screening is uncertain. The Fracture Risk Assessment Tool (FRAX), which includes self-identified racial and ethnic information, and the Osteoporosis Self-assessment
Autor:
Mattias Lorentzon, Helena Johansson, Nicholas C. Harvey, Enwu Liu, Liesbeth Vandenput, Carolyn J. Crandall, Jane A. Cauley, Meryl S. LeBoff, Eugene V. McCloskey, John A. Kanis
Publikováno v:
Osteoporosis International. 33:2297-2305
Summary: In a combined analysis of 25,389 postmenopausal women aged 50–79 years, enrolled in the two Women’s Health Initiative hormone therapy trials, menopausal hormone therapy vs. placebo reduced the risk of fracture regardless of baseline FRAX
Autor:
Brittney S. Lange-Maia, Samar R. El Khoudary, Carolyn J. Crandall, Yanyu Zhang, Carrie A. Karvonen-Gutierrez, Kelley Pettee Gabriel, Bradley M. Appelhans, Elsa S. Strotmeyer, Kelly R. Ylitalo, Kelly Karavolos, Howard M. Kravitz, Sheila A. Dugan, Imke Janssen
Publikováno v:
Journal of aging and health.
Objectives To determine whether physical function (PF) before menopause is related to cardiovascular disease (CVD) risk. Methods Participants were N = 2950 pre-/early peri-menopausal women (median age 46, (25th–75th percentile: 43–48 years). Phys